Depression and diabetes: treatment and health-care delivery

被引:127
作者
Petrak, Frank [1 ,2 ]
Baumeister, Harald [3 ]
Skinner, Timothy C. [4 ]
Brown, Alex [5 ]
Holt, Richard I. G. [6 ]
机构
[1] Ruhr Univ Bochum, LWL Univ Clin Bochum, Dept Psychosomat Med & Psychotherapy, D-65193 Wiesbaden, Germany
[2] Ctr Psychotherapy Wiesbaden, Wiesbaden, Germany
[3] Univ Freiburg, Fac Med, Inst Psychol & Med Psychol & Med Sociol, Dept Rehabil Psychol & Psychotherapy, D-79106 Freiburg, Germany
[4] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT 0909, Australia
[5] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia
[6] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO9 5NH, Hants, England
关键词
MINIMAL PSYCHOLOGICAL INTERVENTION; S2-GUIDELINE PSYCHOSOCIAL-ASPECTS; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; COMORBID MENTAL-DISORDERS; CASE-FINDING INSTRUMENTS; ILL ELDERLY-PATIENTS; COLLABORATIVE CARE; COST-EFFECTIVENESS; MAJOR DEPRESSION;
D O I
10.1016/S2213-8587(15)00045-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite research efforts in the past 20 years, scientific evidence about screening and treatment for depression in diabetes remains incomplete and is mostly focused on North American and European health-care systems. Validated instruments to detect depression in diabetes, although widely available, only become effective and thus recommended if subsequent treatment pathways are accessible, which is often not the case. Because of the well known adverse effects of the interaction between depression and diabetes, treatment goals should focus on the remission or improvement of depression as well as improvement in glycaemic control as a marker for subsequent diabetes outcome. Scientific evidence evaluating treatment for depression in type 1 and type 2 diabetes shows that depression can be treated with moderate success by various psychological and pharmacological interventions, which are often implemented through collaborative care and stepped-care approaches. The evidence for improved glycaemic control in the treatment of depression by use of selective serotonin reuptake inhibitors or psychological approaches is conflicting; only some analyses show small to moderate improvements in glycaemic control. More research is needed to evaluate treatment of different depression subtypes in people with diabetes, the cost-effectiveness of treatments, the use of health-care resources, the need to account for cultural differences and different health-care systems, and new treatment and prevention approaches.
引用
收藏
页码:472 / 485
页数:14
相关论文
共 118 条
[1]   Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study [J].
Alderson, Sarah L. ;
Russell, Amy M. ;
McLintock, Kate ;
Potrata, Barbara ;
House, Allan ;
Foy, Robbie .
BMJ OPEN, 2014, 4 (08)
[2]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[3]   Executive Summary: Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S5-S13
[4]  
[Anonymous], CRIT APPR VIAB EFF A
[5]  
[Anonymous], 2012, Global Guideline for Type 2 Diabetes
[6]  
[Anonymous], 2007, STRUCTURED CLIN INTE
[7]  
[Anonymous], NAT VERS THER TYP 2
[8]  
[Anonymous], 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD011246
[9]   Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis [J].
Atlantis, Evan ;
Fahey, Paul ;
Foster, Jann .
BMJ OPEN, 2014, 4 (04)
[10]  
Australian Bureau of Statistics, 2010, FRAM MEAS WELLB AB T